Glucagon-like peptide 1 (GLP-1) and α-tocopheryl quinone can promote the growth of intestinal flora and affect the pathogenesis of non-alcoholic steatohepatitis (NASH). The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatohepatitis.